Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.00334102 |
2 | synaptic vesicle maturation (GO:0016188) | 5.80038617 |
3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.73379846 |
4 | vocalization behavior (GO:0071625) | 5.65195891 |
5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.55119930 |
6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.51931062 |
7 | locomotory exploration behavior (GO:0035641) | 5.50955105 |
8 | synaptic vesicle exocytosis (GO:0016079) | 5.42244188 |
9 | glutamate secretion (GO:0014047) | 5.27286570 |
10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.17526903 |
11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.16086017 |
12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.10318153 |
13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.95701307 |
14 | protein localization to synapse (GO:0035418) | 4.84477433 |
15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.68982596 |
16 | neuron cell-cell adhesion (GO:0007158) | 4.56144549 |
17 | regulation of synapse structural plasticity (GO:0051823) | 4.47705097 |
18 | regulation of synaptic vesicle transport (GO:1902803) | 4.45949128 |
19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.43333906 |
20 | neurotransmitter secretion (GO:0007269) | 4.42877767 |
21 | exploration behavior (GO:0035640) | 4.29810817 |
22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.27915831 |
23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.18285003 |
24 | synaptic transmission, glutamatergic (GO:0035249) | 4.11519179 |
25 | neuron-neuron synaptic transmission (GO:0007270) | 4.09845350 |
26 | layer formation in cerebral cortex (GO:0021819) | 4.08115169 |
27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.02806466 |
28 | glutamate receptor signaling pathway (GO:0007215) | 4.00828907 |
29 | neuronal action potential propagation (GO:0019227) | 3.96982909 |
30 | positive regulation of synapse maturation (GO:0090129) | 3.91152813 |
31 | gamma-aminobutyric acid transport (GO:0015812) | 3.84742784 |
32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.83207745 |
33 | auditory behavior (GO:0031223) | 3.80588035 |
34 | positive regulation of membrane potential (GO:0045838) | 3.79720224 |
35 | postsynaptic membrane organization (GO:0001941) | 3.76423932 |
36 | thrombin receptor signaling pathway (GO:0070493) | 3.74029993 |
37 | negative regulation of heart rate (GO:0010459) | 3.72347798 |
38 | long-term memory (GO:0007616) | 3.67815765 |
39 | dendritic spine morphogenesis (GO:0060997) | 3.65223302 |
40 | presynaptic membrane assembly (GO:0097105) | 3.64747728 |
41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.63921832 |
42 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.63782154 |
43 | relaxation of smooth muscle (GO:0044557) | 3.63549755 |
44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.63335516 |
45 | activation of protein kinase A activity (GO:0034199) | 3.62934955 |
46 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.62745643 |
47 | long-term synaptic potentiation (GO:0060291) | 3.58728576 |
48 | proline transport (GO:0015824) | 3.55016300 |
49 | regulation of synaptic plasticity (GO:0048167) | 3.54945085 |
50 | detection of calcium ion (GO:0005513) | 3.54064986 |
51 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.52791731 |
52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.52780709 |
53 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.48494390 |
54 | neurotransmitter transport (GO:0006836) | 3.47186242 |
55 | positive regulation of neurotransmitter transport (GO:0051590) | 3.46000424 |
56 | regulation of neurotransmitter secretion (GO:0046928) | 3.45774930 |
57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45325729 |
58 | cellular potassium ion homeostasis (GO:0030007) | 3.42121935 |
59 | response to auditory stimulus (GO:0010996) | 3.39160245 |
60 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.37872372 |
61 | presynaptic membrane organization (GO:0097090) | 3.36891345 |
62 | neuron recognition (GO:0008038) | 3.35840724 |
63 | response to histamine (GO:0034776) | 3.35837712 |
64 | neuromuscular process controlling balance (GO:0050885) | 3.34887680 |
65 | mechanosensory behavior (GO:0007638) | 3.27331308 |
66 | regulation of neurotransmitter levels (GO:0001505) | 3.24267811 |
67 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.23269201 |
68 | regulation of neurotransmitter transport (GO:0051588) | 3.22740570 |
69 | negative regulation of neurotransmitter transport (GO:0051589) | 3.21824353 |
70 | transmission of nerve impulse (GO:0019226) | 3.20782316 |
71 | prepulse inhibition (GO:0060134) | 3.20687150 |
72 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.20575989 |
73 | cerebellar granule cell differentiation (GO:0021707) | 3.20298838 |
74 | regulation of platelet aggregation (GO:0090330) | 3.16996697 |
75 | synaptic vesicle endocytosis (GO:0048488) | 3.12834178 |
76 | regulation of dendritic spine development (GO:0060998) | 3.12449850 |
77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11988593 |
78 | behavioral fear response (GO:0001662) | 3.11747565 |
79 | behavioral defense response (GO:0002209) | 3.11747565 |
80 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.11503952 |
81 | potassium ion import (GO:0010107) | 3.11300265 |
82 | regulation of synapse maturation (GO:0090128) | 3.09628408 |
83 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.09392421 |
84 | positive regulation of synaptic transmission (GO:0050806) | 3.08350135 |
85 | relaxation of muscle (GO:0090075) | 3.08242004 |
86 | regulation of vesicle fusion (GO:0031338) | 3.07757668 |
87 | behavioral response to cocaine (GO:0048148) | 3.07196782 |
88 | membrane hyperpolarization (GO:0060081) | 3.07076678 |
89 | dendrite morphogenesis (GO:0048813) | 3.06341242 |
90 | regulation of female receptivity (GO:0045924) | 3.06018127 |
91 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.05983526 |
92 | sleep (GO:0030431) | 3.05114394 |
93 | membrane depolarization (GO:0051899) | 3.04959859 |
94 | protein neddylation (GO:0045116) | 3.04942882 |
95 | axonal fasciculation (GO:0007413) | 3.04669110 |
96 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.04608546 |
97 | sodium ion export (GO:0071436) | 3.03502321 |
98 | negative regulation of response to food (GO:0032096) | 3.03277500 |
99 | negative regulation of appetite (GO:0032099) | 3.03277500 |
100 | vesicle docking involved in exocytosis (GO:0006904) | 3.02711590 |
101 | synapse assembly (GO:0007416) | 3.02321307 |
102 | female mating behavior (GO:0060180) | 3.01739418 |
103 | learning (GO:0007612) | 3.01092777 |
104 | megakaryocyte development (GO:0035855) | 3.00419904 |
105 | regulation of sensory perception of pain (GO:0051930) | 2.98334623 |
106 | regulation of sensory perception (GO:0051931) | 2.98334623 |
107 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.97064317 |
108 | striatum development (GO:0021756) | 2.96634885 |
109 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.95915344 |
110 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94471108 |
111 | regulation of synaptic transmission (GO:0050804) | 2.93225030 |
112 | synaptic transmission (GO:0007268) | 2.92803840 |
113 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.92766621 |
114 | fear response (GO:0042596) | 2.92512331 |
115 | vesicle transport along microtubule (GO:0047496) | 2.92324690 |
116 | cell communication by electrical coupling (GO:0010644) | 2.91911221 |
117 | aggressive behavior (GO:0002118) | 2.91905994 |
118 | membrane depolarization during action potential (GO:0086010) | 2.91382560 |
119 | negative regulation of heart contraction (GO:0045822) | 2.91346348 |
120 | neuromuscular process (GO:0050905) | 2.90741178 |
121 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.90663927 |
122 | vesicle docking (GO:0048278) | 2.88844509 |
123 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88685445 |
124 | long term synaptic depression (GO:0060292) | 2.88042015 |
125 | regulation of glutamate secretion (GO:0014048) | 2.71706595 |
126 | neurotransmitter uptake (GO:0001504) | 2.71115064 |
127 | relaxation of cardiac muscle (GO:0055119) | 2.68830463 |
128 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.68383285 |
129 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.68383285 |
130 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.65634789 |
131 | positive regulation of muscle hypertrophy (GO:0014742) | 2.65634789 |
132 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.64941841 |
133 | regulation of platelet activation (GO:0010543) | 2.64162308 |
134 | regulation of exocytosis (GO:0017157) | 2.63482838 |
135 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.62962713 |
136 | response to amphetamine (GO:0001975) | 2.61576461 |
137 | negative regulation of cation channel activity (GO:2001258) | 2.61042012 |
138 | nerve growth factor signaling pathway (GO:0038180) | 2.57030244 |
139 | serotonin metabolic process (GO:0042428) | 2.56033024 |
140 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.54271498 |
141 | monoamine transport (GO:0015844) | 2.53638305 |
142 | neuronal action potential (GO:0019228) | 2.51296313 |
143 | positive regulation of amino acid transport (GO:0051957) | 2.50992547 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.32923719 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.79830975 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19777626 |
4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.11366051 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99018734 |
6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.71634851 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69325031 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69325031 |
9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62747601 |
10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.62741625 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60163607 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54651438 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54412711 |
14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51330703 |
15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50851601 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50376167 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50120505 |
18 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24713635 |
19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24170814 |
20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21580155 |
21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18636303 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16515375 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15902277 |
24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.08972427 |
25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01042112 |
26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97271722 |
27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97099529 |
28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95805947 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91997624 |
30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86849062 |
31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.86780591 |
32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84681750 |
33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84279017 |
34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82092611 |
35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80020158 |
36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71709028 |
37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67603395 |
38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67221084 |
39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66192902 |
40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62535813 |
41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50398809 |
42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48819923 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48036338 |
44 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46775467 |
45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45276952 |
46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42931949 |
47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42441604 |
48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40898301 |
49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40020903 |
50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40019327 |
51 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38559111 |
52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36709722 |
53 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.35744696 |
54 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33774206 |
55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31356722 |
56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30601608 |
57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30368519 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30368519 |
59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28374034 |
60 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28263889 |
61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27388335 |
62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25717997 |
63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25079710 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23943412 |
65 | AR_19668381_ChIP-Seq_PC3_Human | 1.23335593 |
66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23064692 |
67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22896386 |
68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.22361740 |
69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20950902 |
70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20750063 |
71 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20039998 |
72 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20039365 |
73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19545367 |
74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18610791 |
75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18411938 |
76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18360186 |
77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18347744 |
78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18269266 |
79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17793896 |
80 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15965342 |
81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15666333 |
82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15068784 |
83 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14699752 |
84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14290451 |
85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13929981 |
86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13001100 |
87 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10886264 |
88 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09737902 |
89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09705637 |
90 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08653073 |
91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08653073 |
92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07953209 |
93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07833315 |
94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07124741 |
95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06698622 |
96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06534140 |
97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06464598 |
98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06462878 |
99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06339967 |
100 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06268226 |
101 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05121155 |
102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04948223 |
103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04638447 |
104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03939026 |
105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02461772 |
106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02364739 |
107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01892825 |
108 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01731025 |
109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01390206 |
110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01272591 |
111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00863737 |
112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00668659 |
113 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00311381 |
114 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00311381 |
115 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99059061 |
116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98692928 |
117 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97001160 |
118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96590707 |
119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96282636 |
120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96010458 |
121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95898354 |
122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95624218 |
123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94381710 |
124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94040546 |
125 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93385565 |
126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93032856 |
127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92043680 |
128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90901173 |
129 | JUN_21703547_ChIP-Seq_K562_Human | 0.88876895 |
130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87832879 |
131 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87514044 |
132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87201527 |
133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84977290 |
134 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84869580 |
135 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.84344619 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.52958695 |
2 | MP0003880_abnormal_central_pattern | 4.75788006 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.24483045 |
4 | MP0004270_analgesia | 3.66388139 |
5 | MP0002822_catalepsy | 3.64773413 |
6 | MP0009745_abnormal_behavioral_response | 3.55699953 |
7 | MP0002063_abnormal_learning/memory/cond | 3.45555066 |
8 | * MP0005464_abnormal_platelet_physiology | 3.22774228 |
9 | MP0002064_seizures | 3.21028600 |
10 | MP0009046_muscle_twitch | 3.10685431 |
11 | MP0001968_abnormal_touch/_nociception | 2.95988468 |
12 | MP0002572_abnormal_emotion/affect_behav | 2.85140489 |
13 | MP0005423_abnormal_somatic_nervous | 2.62771539 |
14 | MP0001486_abnormal_startle_reflex | 2.62665167 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.53222845 |
16 | MP0002272_abnormal_nervous_system | 2.51085621 |
17 | MP0009780_abnormal_chondrocyte_physiolo | 2.34280911 |
18 | MP0002736_abnormal_nociception_after | 2.31697739 |
19 | MP0001501_abnormal_sleep_pattern | 2.26378493 |
20 | MP0008004_abnormal_stomach_pH | 2.24138800 |
21 | MP0001440_abnormal_grooming_behavior | 2.07613798 |
22 | MP0002067_abnormal_sensory_capabilities | 1.88644345 |
23 | MP0002735_abnormal_chemical_nociception | 1.87773789 |
24 | MP0008569_lethality_at_weaning | 1.84055296 |
25 | MP0002733_abnormal_thermal_nociception | 1.82393288 |
26 | MP0001970_abnormal_pain_threshold | 1.81904947 |
27 | MP0005386_behavior/neurological_phenoty | 1.81519707 |
28 | MP0004924_abnormal_behavior | 1.81519707 |
29 | MP0002909_abnormal_adrenal_gland | 1.76868717 |
30 | MP0004811_abnormal_neuron_physiology | 1.74246437 |
31 | MP0003879_abnormal_hair_cell | 1.73186568 |
32 | MP0005646_abnormal_pituitary_gland | 1.72385173 |
33 | MP0002557_abnormal_social/conspecific_i | 1.72118371 |
34 | MP0003329_amyloid_beta_deposits | 1.70541257 |
35 | MP0000778_abnormal_nervous_system | 1.69997384 |
36 | MP0008877_abnormal_DNA_methylation | 1.69641185 |
37 | MP0002184_abnormal_innervation | 1.65942748 |
38 | MP0003787_abnormal_imprinting | 1.61147609 |
39 | MP0003724_increased_susceptibility_to | 1.57335791 |
40 | MP0001984_abnormal_olfaction | 1.53915156 |
41 | MP0004858_abnormal_nervous_system | 1.50954394 |
42 | MP0002138_abnormal_hepatobiliary_system | 1.45495683 |
43 | MP0000955_abnormal_spinal_cord | 1.42352238 |
44 | MP0001529_abnormal_vocalization | 1.41850739 |
45 | MP0004885_abnormal_endolymph | 1.39027987 |
46 | MP0002066_abnormal_motor_capabilities/c | 1.38463023 |
47 | MP0003633_abnormal_nervous_system | 1.36414729 |
48 | MP0002882_abnormal_neuron_morphology | 1.35122770 |
49 | * MP0000230_abnormal_systemic_arterial | 1.35017004 |
50 | MP0000751_myopathy | 1.31175440 |
51 | MP0003122_maternal_imprinting | 1.29111256 |
52 | MP0004147_increased_porphyrin_level | 1.27076603 |
53 | MP0001502_abnormal_circadian_rhythm | 1.23250038 |
54 | MP0001188_hyperpigmentation | 1.22653700 |
55 | MP0006276_abnormal_autonomic_nervous | 1.19357699 |
56 | MP0003195_calcinosis | 1.19065633 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.17240816 |
58 | MP0000013_abnormal_adipose_tissue | 1.16354086 |
59 | MP0004085_abnormal_heartbeat | 1.14038714 |
60 | MP0002638_abnormal_pupillary_reflex | 1.13946420 |
61 | MP0001905_abnormal_dopamine_level | 1.13070152 |
62 | MP0003631_nervous_system_phenotype | 1.12036266 |
63 | MP0005551_abnormal_eye_electrophysiolog | 1.11204780 |
64 | MP0002837_dystrophic_cardiac_calcinosis | 1.10636386 |
65 | MP0004142_abnormal_muscle_tone | 1.09536406 |
66 | MP0003045_fibrosis | 1.09324454 |
67 | MP0005645_abnormal_hypothalamus_physiol | 1.05188343 |
68 | MP0004215_abnormal_myocardial_fiber | 1.05151622 |
69 | MP0002152_abnormal_brain_morphology | 1.04866324 |
70 | MP0008872_abnormal_physiological_respon | 1.01815076 |
71 | MP0001177_atelectasis | 1.01324209 |
72 | MP0008874_decreased_physiological_sensi | 0.98713019 |
73 | MP0004084_abnormal_cardiac_muscle | 0.97401177 |
74 | MP0003172_abnormal_lysosome_physiology | 0.95063970 |
75 | MP0002069_abnormal_eating/drinking_beha | 0.94003723 |
76 | MP0008775_abnormal_heart_ventricle | 0.90697213 |
77 | MP0005167_abnormal_blood-brain_barrier | 0.89913455 |
78 | MP0004233_abnormal_muscle_weight | 0.89815535 |
79 | MP0004145_abnormal_muscle_electrophysio | 0.89631348 |
80 | MP0002229_neurodegeneration | 0.88978112 |
81 | MP0001986_abnormal_taste_sensitivity | 0.88748403 |
82 | MP0004484_altered_response_of | 0.88260614 |
83 | MP0003075_altered_response_to | 0.87926256 |
84 | MP0002090_abnormal_vision | 0.87384697 |
85 | * MP0005084_abnormal_gallbladder_morpholo | 0.87032233 |
86 | MP0010386_abnormal_urinary_bladder | 0.84755790 |
87 | MP0008961_abnormal_basal_metabolism | 0.84429440 |
88 | MP0003252_abnormal_bile_duct | 0.84157365 |
89 | MP0002928_abnormal_bile_duct | 0.82395206 |
90 | MP0003137_abnormal_impulse_conducting | 0.82133409 |
91 | MP0005410_abnormal_fertilization | 0.80562047 |
92 | MP0003690_abnormal_glial_cell | 0.77534696 |
93 | MP0005535_abnormal_body_temperature | 0.77307863 |
94 | MP0002693_abnormal_pancreas_physiology | 0.77127474 |
95 | MP0000569_abnormal_digit_pigmentation | 0.77052067 |
96 | MP0003634_abnormal_glial_cell | 0.76441162 |
97 | MP0005623_abnormal_meninges_morphology | 0.75683199 |
98 | MP0004130_abnormal_muscle_cell | 0.73093010 |
99 | MP0001765_abnormal_ion_homeostasis | 0.72890040 |
100 | MP0001963_abnormal_hearing_physiology | 0.72767259 |
101 | MP0004742_abnormal_vestibular_system | 0.72540348 |
102 | MP0003632_abnormal_nervous_system | 0.70594100 |
103 | MP0000631_abnormal_neuroendocrine_gland | 0.69766259 |
104 | MP0003638_abnormal_response/metabolism_ | 0.69696873 |
105 | MP0000604_amyloidosis | 0.69247427 |
106 | MP0002752_abnormal_somatic_nervous | 0.67851262 |
107 | MP0004036_abnormal_muscle_relaxation | 0.67803903 |
108 | MP0005174_abnormal_tail_pigmentation | 0.66585076 |
109 | MP0001756_abnormal_urination | 0.66463618 |
110 | MP0004043_abnormal_pH_regulation | 0.65952514 |
111 | MP0005620_abnormal_muscle_contractility | 0.65206682 |
112 | MP0003121_genomic_imprinting | 0.65042407 |
113 | MP0010329_abnormal_lipoprotein_level | 0.64654577 |
114 | MP0002876_abnormal_thyroid_physiology | 0.64285035 |
115 | MP0005499_abnormal_olfactory_system | 0.64155788 |
116 | MP0005394_taste/olfaction_phenotype | 0.64155788 |
117 | MP0000920_abnormal_myelination | 0.64127193 |
118 | MP0003646_muscle_fatigue | 0.61684067 |
119 | MP0001485_abnormal_pinna_reflex | 0.61390797 |
120 | MP0005409_darkened_coat_color | 0.59743191 |
121 | MP0003283_abnormal_digestive_organ | 0.58553116 |
122 | MP0001943_abnormal_respiration | 0.58259193 |
123 | * MP0001664_abnormal_digestion | 0.53382822 |
124 | MP0004510_myositis | 0.52995430 |
125 | * MP0010769_abnormal_survival | 0.51286568 |
126 | MP0005187_abnormal_penis_morphology | 0.50655226 |
127 | * MP0010770_preweaning_lethality | 0.50342587 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.88817710 |
2 | Myokymia (HP:0002411) | 6.79877641 |
3 | Prolonged bleeding time (HP:0003010) | 5.74822771 |
4 | Focal seizures (HP:0007359) | 5.68861793 |
5 | Epileptic encephalopathy (HP:0200134) | 5.49692551 |
6 | Visual hallucinations (HP:0002367) | 4.88091087 |
7 | Atonic seizures (HP:0010819) | 4.61272679 |
8 | Increased mean platelet volume (HP:0011877) | 4.48660857 |
9 | Petechiae (HP:0000967) | 4.44858877 |
10 | Febrile seizures (HP:0002373) | 4.33536037 |
11 | Absence seizures (HP:0002121) | 4.13254909 |
12 | Abnormal platelet volume (HP:0011876) | 4.06301828 |
13 | Menorrhagia (HP:0000132) | 4.05489788 |
14 | Hyperventilation (HP:0002883) | 3.90630810 |
15 | Progressive cerebellar ataxia (HP:0002073) | 3.88517910 |
16 | Broad-based gait (HP:0002136) | 3.85228758 |
17 | Dialeptic seizures (HP:0011146) | 3.78532099 |
18 | Generalized tonic-clonic seizures (HP:0002069) | 3.75770650 |
19 | Purpura (HP:0000979) | 3.66707839 |
20 | Poor eye contact (HP:0000817) | 3.61471035 |
21 | Action tremor (HP:0002345) | 3.48370928 |
22 | Ankle clonus (HP:0011448) | 3.30086921 |
23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.27809483 |
24 | Impaired social interactions (HP:0000735) | 3.27631761 |
25 | Abnormal social behavior (HP:0012433) | 3.27631761 |
26 | Depression (HP:0000716) | 3.26343725 |
27 | Dysdiadochokinesis (HP:0002075) | 3.19722071 |
28 | Gaze-evoked nystagmus (HP:0000640) | 3.18896181 |
29 | Epistaxis (HP:0000421) | 3.17577694 |
30 | Abnormal eating behavior (HP:0100738) | 3.12167279 |
31 | Anxiety (HP:0000739) | 3.03975499 |
32 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.03962236 |
33 | Supranuclear gaze palsy (HP:0000605) | 3.03322956 |
34 | Torticollis (HP:0000473) | 2.96990562 |
35 | Mutism (HP:0002300) | 2.95695666 |
36 | Amblyopia (HP:0000646) | 2.90613915 |
37 | Gingival bleeding (HP:0000225) | 2.86359800 |
38 | Dysmetria (HP:0001310) | 2.85489527 |
39 | Papilledema (HP:0001085) | 2.84343465 |
40 | Truncal ataxia (HP:0002078) | 2.80326160 |
41 | Drooling (HP:0002307) | 2.80099304 |
42 | Excessive salivation (HP:0003781) | 2.80099304 |
43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.78188388 |
44 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.78188388 |
45 | Postural instability (HP:0002172) | 2.77595307 |
46 | Abnormality of the lower motor neuron (HP:0002366) | 2.76614785 |
47 | Dysmetric saccades (HP:0000641) | 2.69668349 |
48 | Focal dystonia (HP:0004373) | 2.68501492 |
49 | Urinary urgency (HP:0000012) | 2.66208393 |
50 | Epileptiform EEG discharges (HP:0011182) | 2.62682638 |
51 | Stereotypic behavior (HP:0000733) | 2.58187994 |
52 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.56613439 |
53 | Genetic anticipation (HP:0003743) | 2.56005888 |
54 | Progressive inability to walk (HP:0002505) | 2.55276451 |
55 | Annular pancreas (HP:0001734) | 2.54213588 |
56 | Scanning speech (HP:0002168) | 2.53994981 |
57 | Abnormality of binocular vision (HP:0011514) | 2.47617547 |
58 | Diplopia (HP:0000651) | 2.47617547 |
59 | Impaired smooth pursuit (HP:0007772) | 2.46538844 |
60 | Hemiparesis (HP:0001269) | 2.46324881 |
61 | Abnormal platelet function (HP:0011869) | 2.46286369 |
62 | Impaired platelet aggregation (HP:0003540) | 2.46286369 |
63 | Craniofacial dystonia (HP:0012179) | 2.45055022 |
64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44035865 |
65 | Hyperlipoproteinemia (HP:0010980) | 2.43898342 |
66 | Pheochromocytoma (HP:0002666) | 2.42395475 |
67 | Spastic gait (HP:0002064) | 2.42315006 |
68 | Termporal pattern (HP:0011008) | 2.42042007 |
69 | Insidious onset (HP:0003587) | 2.42042007 |
70 | Polyphagia (HP:0002591) | 2.39755156 |
71 | Hypothermia (HP:0002045) | 2.39368173 |
72 | Bradykinesia (HP:0002067) | 2.36446970 |
73 | Hemiplegia (HP:0002301) | 2.34287538 |
74 | Inability to walk (HP:0002540) | 2.33909498 |
75 | Limb dystonia (HP:0002451) | 2.33597803 |
76 | Hypsarrhythmia (HP:0002521) | 2.32001356 |
77 | Impaired vibratory sensation (HP:0002495) | 2.31526967 |
78 | Resting tremor (HP:0002322) | 2.31300047 |
79 | Abnormality of the corticospinal tract (HP:0002492) | 2.29003391 |
80 | Neurofibrillary tangles (HP:0002185) | 2.28836035 |
81 | Ketoacidosis (HP:0001993) | 2.27585900 |
82 | Cerebral inclusion bodies (HP:0100314) | 2.26561414 |
83 | Intention tremor (HP:0002080) | 2.23749857 |
84 | Status epilepticus (HP:0002133) | 2.22480849 |
85 | Increased circulating renin level (HP:0000848) | 2.21299996 |
86 | Absent speech (HP:0001344) | 2.20908022 |
87 | Megalencephaly (HP:0001355) | 2.19656930 |
88 | Fetal akinesia sequence (HP:0001989) | 2.17090996 |
89 | Hypomagnesemia (HP:0002917) | 2.16976396 |
90 | Lower limb muscle weakness (HP:0007340) | 2.14883701 |
91 | Ventricular fibrillation (HP:0001663) | 2.12085207 |
92 | Polydipsia (HP:0001959) | 2.11545189 |
93 | Abnormal drinking behavior (HP:0030082) | 2.11545189 |
94 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10992880 |
95 | Incomplete penetrance (HP:0003829) | 2.09375765 |
96 | Tetraplegia (HP:0002445) | 2.08661084 |
97 | Amyotrophic lateral sclerosis (HP:0007354) | 2.06423719 |
98 | Generalized myoclonic seizures (HP:0002123) | 2.05827370 |
99 | Blue irides (HP:0000635) | 2.04597558 |
100 | Pointed chin (HP:0000307) | 2.03849752 |
101 | Lower limb amyotrophy (HP:0007210) | 2.03315093 |
102 | Neuroendocrine neoplasm (HP:0100634) | 2.02729949 |
103 | Delusions (HP:0000746) | 1.95941142 |
104 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.95559642 |
105 | Abnormal EKG (HP:0003115) | 1.94037558 |
106 | Decreased central vision (HP:0007663) | 1.93396384 |
107 | Hyperthyroidism (HP:0000836) | 1.92619210 |
108 | Protruding tongue (HP:0010808) | 1.92591925 |
109 | Gait ataxia (HP:0002066) | 1.89659493 |
110 | Prolonged QT interval (HP:0001657) | 1.88812879 |
111 | Obstructive sleep apnea (HP:0002870) | 1.87134570 |
112 | Hypoventilation (HP:0002791) | 1.86440330 |
113 | Failure to thrive in infancy (HP:0001531) | 1.84863066 |
114 | Gait imbalance (HP:0002141) | 1.84615410 |
115 | Intellectual disability, profound (HP:0002187) | 1.83626450 |
116 | Ankyloglossia (HP:0010296) | 1.83278703 |
117 | Central scotoma (HP:0000603) | 1.82671798 |
118 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.82221747 |
119 | Abnormality of salivation (HP:0100755) | 1.81340484 |
120 | Spastic tetraparesis (HP:0001285) | 1.80584062 |
121 | Agitation (HP:0000713) | 1.80077218 |
122 | Medial flaring of the eyebrow (HP:0010747) | 1.80013933 |
123 | Hypoglycemic seizures (HP:0002173) | 1.79142654 |
124 | Hypoglycemic coma (HP:0001325) | 1.78844553 |
125 | Clonus (HP:0002169) | 1.77670155 |
126 | Bundle branch block (HP:0011710) | 1.77416079 |
127 | Specific learning disability (HP:0001328) | 1.76477826 |
128 | Inappropriate behavior (HP:0000719) | 1.76269466 |
129 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.75205337 |
130 | Hyperphosphatemia (HP:0002905) | 1.74905616 |
131 | Muscular hypotonia of the trunk (HP:0008936) | 1.73597296 |
132 | Akinesia (HP:0002304) | 1.72654938 |
133 | Thickened helices (HP:0000391) | 1.72603188 |
134 | Abnormality of saccadic eye movements (HP:0000570) | 1.71788663 |
135 | Poikilocytosis (HP:0004447) | 1.71657346 |
136 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.71316232 |
137 | Sudden death (HP:0001699) | 1.70519354 |
138 | Widely spaced teeth (HP:0000687) | 1.67636993 |
139 | Papillary thyroid carcinoma (HP:0002895) | 1.64130977 |
140 | Syncope (HP:0001279) | 1.63462573 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.67839551 |
2 | NTRK3 | 3.97822503 |
3 | MAP4K2 | 3.65062488 |
4 | MAP3K9 | 3.58487157 |
5 | MARK1 | 3.44992758 |
6 | DAPK2 | 3.01815192 |
7 | CASK | 3.00311724 |
8 | MAP3K4 | 2.98322395 |
9 | FRK | 2.75863595 |
10 | MAP2K7 | 2.58669682 |
11 | MINK1 | 2.48999249 |
12 | PAK6 | 2.18609806 |
13 | KSR2 | 2.04094662 |
14 | NTRK2 | 1.96224384 |
15 | CAMKK1 | 1.85659877 |
16 | MAP3K12 | 1.82875008 |
17 | DAPK1 | 1.82404728 |
18 | MAP2K4 | 1.81889032 |
19 | PRKD3 | 1.73036340 |
20 | CDK19 | 1.64234682 |
21 | KSR1 | 1.62268317 |
22 | PRPF4B | 1.61080706 |
23 | PLK2 | 1.57377642 |
24 | NTRK1 | 1.55981098 |
25 | CDK5 | 1.54326466 |
26 | TAOK3 | 1.40529917 |
27 | TEC | 1.36366818 |
28 | CCNB1 | 1.29893709 |
29 | TNIK | 1.28998543 |
30 | RIPK4 | 1.27955932 |
31 | MAPK13 | 1.26465928 |
32 | MST4 | 1.25567652 |
33 | CAMKK2 | 1.17306510 |
34 | GRK5 | 1.16825691 |
35 | STK38 | 1.16660529 |
36 | PHKG2 | 1.15941106 |
37 | PHKG1 | 1.15941106 |
38 | PRKCG | 1.14855805 |
39 | TAOK1 | 1.14281607 |
40 | MYLK | 1.13721962 |
41 | FES | 1.09087918 |
42 | MAP3K2 | 1.08106686 |
43 | ARAF | 1.06786494 |
44 | SIK2 | 1.04592876 |
45 | ADRBK2 | 1.02611713 |
46 | FGFR2 | 1.01638983 |
47 | TYRO3 | 0.98397947 |
48 | CAMK2A | 0.97712434 |
49 | SGK494 | 0.96047827 |
50 | SGK223 | 0.96047827 |
51 | OXSR1 | 0.95314052 |
52 | CDK18 | 0.94625230 |
53 | CAMK1 | 0.92443926 |
54 | CDK15 | 0.91838569 |
55 | MAP3K13 | 0.91104188 |
56 | NEK1 | 0.90980087 |
57 | SYK | 0.90725821 |
58 | PTK2B | 0.90145461 |
59 | GRK1 | 0.89946608 |
60 | CDK14 | 0.88978068 |
61 | UHMK1 | 0.88706006 |
62 | LATS2 | 0.87317271 |
63 | AKT3 | 0.86725939 |
64 | MAPKAPK3 | 0.86159401 |
65 | STK11 | 0.85452627 |
66 | PRKCH | 0.85275383 |
67 | SGK2 | 0.84962508 |
68 | CSNK1G3 | 0.82872812 |
69 | RAF1 | 0.80073413 |
70 | BMX | 0.80007900 |
71 | CDK11A | 0.78733966 |
72 | RET | 0.76529125 |
73 | CAMK2B | 0.76165253 |
74 | NUAK1 | 0.74792307 |
75 | MARK2 | 0.74379691 |
76 | SGK3 | 0.73496366 |
77 | PNCK | 0.73177532 |
78 | PAK3 | 0.72353367 |
79 | BMPR1B | 0.71168297 |
80 | SGK1 | 0.69791089 |
81 | CSNK1G1 | 0.68627142 |
82 | PINK1 | 0.65777232 |
83 | DAPK3 | 0.64619038 |
84 | PRKG1 | 0.63040869 |
85 | CSNK1G2 | 0.62646839 |
86 | PDK1 | 0.61111945 |
87 | BCR | 0.60657236 |
88 | INSRR | 0.60652463 |
89 | DYRK1A | 0.60403679 |
90 | LMTK2 | 0.59705908 |
91 | PDPK1 | 0.59681260 |
92 | IRAK2 | 0.58232510 |
93 | PRKCE | 0.57689282 |
94 | ALK | 0.57112900 |
95 | TRPM7 | 0.56271941 |
96 | PDK4 | 0.55267046 |
97 | PDK3 | 0.55267046 |
98 | ADRBK1 | 0.54452317 |
99 | TRIM28 | 0.53059501 |
100 | PRKG2 | 0.51764696 |
101 | DMPK | 0.50971217 |
102 | MAPK12 | 0.50871073 |
103 | MAP3K1 | 0.50867229 |
104 | PRKCZ | 0.50751645 |
105 | BMPR2 | 0.50342527 |
106 | MAP2K6 | 0.49337165 |
107 | STK39 | 0.49024301 |
108 | FER | 0.48602784 |
109 | MAPKAPK5 | 0.48480727 |
110 | RPS6KA3 | 0.47893673 |
111 | PRKCA | 0.47588464 |
112 | FYN | 0.47355603 |
113 | CAMK4 | 0.47118256 |
114 | CDK3 | 0.46989656 |
115 | CDC42BPA | 0.45485111 |
116 | MAP2K1 | 0.45026285 |
117 | PRKCQ | 0.44056861 |
118 | RIPK1 | 0.44052276 |
119 | PRKACA | 0.43482056 |
120 | MAP3K7 | 0.40945619 |
121 | PRKCB | 0.40424732 |
122 | CAMK2D | 0.39227165 |
123 | CSF1R | 0.38837062 |
124 | PKN1 | 0.38706431 |
125 | NEK6 | 0.38535250 |
126 | PIK3CG | 0.38070174 |
127 | PRKACG | 0.37933058 |
128 | CAMK2G | 0.36689017 |
129 | MAP3K6 | 0.35876075 |
130 | SIK3 | 0.35468853 |
131 | TNK2 | 0.34033812 |
132 | MAPK10 | 0.33171249 |
133 | ERBB3 | 0.32675818 |
134 | RPS6KA2 | 0.31335731 |
135 | FGR | 0.30679375 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.62064914 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.39465926 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.88253231 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.75029758 |
5 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.68506612 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.67446230 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.63275933 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.55402161 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47589696 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43155332 |
11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17268942 |
12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.03189323 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.00829548 |
14 | * Platelet activation_Homo sapiens_hsa04611 | 1.98806617 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 1.94302789 |
16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.91899026 |
17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82372360 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80265881 |
19 | * Renin secretion_Homo sapiens_hsa04924 | 1.77038039 |
20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71186478 |
21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68129114 |
22 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67357748 |
23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65596022 |
24 | Taste transduction_Homo sapiens_hsa04742 | 1.61434021 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60771165 |
26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59231039 |
27 | * Long-term depression_Homo sapiens_hsa04730 | 1.50566828 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36514582 |
29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33936765 |
30 | * Gap junction_Homo sapiens_hsa04540 | 1.32946121 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29994902 |
32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27163390 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24219588 |
34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18660949 |
35 | Axon guidance_Homo sapiens_hsa04360 | 1.14380788 |
36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10937897 |
37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10630056 |
38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09297069 |
39 | Glioma_Homo sapiens_hsa05214 | 1.09176903 |
40 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08079380 |
41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07431729 |
42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04019711 |
43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02494176 |
44 | Phototransduction_Homo sapiens_hsa04744 | 1.01428519 |
45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99184974 |
46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99002568 |
47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98716066 |
48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97159962 |
49 | Melanogenesis_Homo sapiens_hsa04916 | 0.96984840 |
50 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96388638 |
51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83598061 |
52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82397697 |
53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80617789 |
54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78639334 |
55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78387736 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76932502 |
57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76699878 |
58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76177870 |
59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74863346 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74794216 |
61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73841804 |
62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71641376 |
63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71424780 |
64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71128521 |
65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70190112 |
66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69514081 |
67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67005583 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64505106 |
69 | Asthma_Homo sapiens_hsa05310 | 0.63840792 |
70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61416380 |
71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60866272 |
72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60641037 |
73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60186952 |
74 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59208052 |
75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59135235 |
76 | ABC transporters_Homo sapiens_hsa02010 | 0.56995396 |
77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56655581 |
78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54692916 |
79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54261101 |
80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54014908 |
81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52228097 |
82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51151674 |
83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50961771 |
84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50181211 |
85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50109621 |
86 | Alcoholism_Homo sapiens_hsa05034 | 0.50021703 |
87 | Bile secretion_Homo sapiens_hsa04976 | 0.49613935 |
88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49338515 |
89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49101814 |
90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47541153 |
91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47015994 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46209180 |
93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45638545 |
94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45386695 |
95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44931975 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.44710241 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43983798 |
98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43912428 |
99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43336140 |
100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42469731 |
101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41956470 |
102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41863636 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41534251 |
104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41030958 |
105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40701625 |
106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40636670 |
107 | Prion diseases_Homo sapiens_hsa05020 | 0.40546572 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37583413 |
109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37106200 |
110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35939093 |
111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35875644 |
112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35470203 |
113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35415949 |
114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35193404 |
115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33703617 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33119466 |
117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32465175 |
118 | Peroxisome_Homo sapiens_hsa04146 | 0.32330736 |
119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31514559 |
120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30732012 |
121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30556285 |
122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29027222 |
123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28229748 |